Replies to post #1303 on Target Group Inc (CBDY)

[abazaba375]

$CBDY DD PACKAGE
~Share Structure
Market Cap Market Cap 17,203,566 06/18/2021
Authorized Shares 850,000,000 06/14/2021
Outstanding Shares 573,452,193 06/14/2021
Restricted 378,291,902 06/14/2021
Unrestricted 195,160,291
06/14/2021 Held at DTC 192,157,261
06/14/2021
Float
180,708,454
05/17/

COMPANY WEBSITE http://www.targetgroupinc.ca/
https://www.instagram.com/targetgroupinc/
MUST READY Q2 IG PROSPECTUS http://www.targetgroupinc.ca/wp-content/uploads/2021/03/Target-Group-Inc-Investor-Deck-Q2-2021-2.pdf


DAILY CHART
[img]http://s3.tradingview.com/snapshots/z/zdjBPFls.png
[/img]
30 MINUTE


WEEKLY CHART



RECENT NEWS



On June 15, 2021, the Company distributed a newsletter to its shareholders announcing that its wholly owned subsidiary, CanaryRx Inc., has received its Health Canada sales license which will permit Canary Rx Inc. to manufacture and sell cannabis products directly to provincial distributors and other authorized Canadian retail supply channels.

Newsletter dated June 15, 2021

6/15/2021 Good morning Target Group shareholders,



We hope everyone has been well & staying safe during these unprecedented times. As the global economy begins reopening, we hope that things can return to normal as quickly as possible.



It gives us great pleasure to announce that on Friday, June 4th, 2021, Target Group Inc’s wholly-owned subsidiary, Canary Rx Inc. (“Canary” or the “Company”), received its Health Canada sales license. This Sales License will allow Canary RX to manufacture and sell Cannabis products directly to provincial distributors and other authorized Canadian retail supply channels. In addition, this license will enable the organization to execute its future CPG strategy of bringing high-quality, strategically segmented consumer brands to market and providing third-party processing and co-packing services on behalf of other licensed white-label partners.

THIS IS MASSIVE news ! pple are sleeping on this

Canary RX, through its joint venture partnership, Venn Cannabis, has been working meticulously to ensure the production of ultra-premium craft cannabis in its 44,000 square foot Simcoe, Ontario production facility. The partnership will continue to allow the delivery of Venn’s unique genetic offerings and provide a robust platform for other retail brands in the market. This will allow us to build a portfolio of whole flower consumer products. Canary RX has already successfully transacted with several additional licenced producers. Over the next 12-18 months, we are optimistic that we can establish Target Group as a leader in contract-based craft cultivation at scale within the Canadian cannabis landscape. To date, Canary RX’s products have been perceived very well in the marketplace, allowing us to secure sales with several tier 1 Cannabis producers/retailers.



Canary recently completed a $500,000 sale and is currently looking to secure multiple long-term supply agreements that will assist in cementing Canary’s long-term success with numerous partners.



In addition to obtaining our sales license and developing long-term supply agreements, Canary RX will continue to upgrade its 44,000 sq ft facility to facilitate a more efficient cultivation process. Implementing a new automated watering system and modifications to the current air flows and growing medium are some of the necessary upgrades needed to optimize the production process.



We are excited to continue offering our customers superior quality products that meet the needs of the constantly evolving and changing Cannabis market. We believe that there will always be a strong demand in this market for craft Cannabis and we intend to capitalize on it.



Stay tuned over the next few months as we continue to grow and establish Canary RX as an industry leader in delivering high-quality Cannabis products.



Warmest Regards,
Tony Zarcone
President & CEO
Target Group Inc.
905-541-3833

20 Hempstead Drive, Hamilton, Ontario L8W 2E7
www.targetgroupinc.ca

02/24/2021
Canary RX Inc. Completes its First 3 Wholesale Transactions of its Cannabis to Multiple Canadian Licensed Producers
Canada NewsWire

NORFOLK COUNTY, ON, Feb. 24, 2021

NORFOLK COUNTY, ON, Feb. 24, 2021 /CNW/ - Target Group Inc. (OTCQB: CBDY) is pleased to announce that its wholly owned subsidiary, Canary Rx Inc. ("Canary" or the "Company") has completed its first three (3) B2B wholesale cannabis transactions through its strategic joint-venture, Venn Cannabis, marking the beginning of a promising future for the company.

Canary RX Inc. Logo (CNW Group/Target Group Inc.)

Canary RX, through its joint venture partnership, Venn Cannabis, has been working meticulously to ensure production of ultra-premium, craft cannabis in its Simcoe, Ontario production facility, enabling delivery of its unique genetic offerings and providing a strong platform for other retail brands in the market to build a portfolio of whole flower consumer products. The company is currently in discussions with several additional licenced producers and is very optimistic that over the next year, can establish itself as a leader in contract-based craft cultivation at scale within the Canadian cannabis landscape.

"These transactions represent several strategic revenue opportunities for Target Group through potential partnerships and long-term supply agreements and builds Canary Rx's Canadian wholesale operations," said Tony Zarcone, CEO of Target Group.

About Canary Rx Inc.
Canary Rx Inc. ("Canary") is a Licensed Producer under the Cannabis Act. Situated in Ontario's Garden, Norfolk County, Canary lies nestled amongst the shores of Lake Erie in a vibrant, agricultural community. Our 44,000 sq. ft. facility is engineered to meet strict quality standards and equipped with the latest environmental control technology. The production space includes eight separate flower rooms, projected to produce up to 4,500kg cannabis per year. Canary's talented team will cultivate premium, craft cannabis, while aligning with distinguished, veteran brands to bring the highest quality product to market. www.canaryrx.com




CBDY PARTNERS ~ http://www.targetgroupinc.ca/partners/

Canary is a prospective Cannabis producer in the final stage of licensing under Canada’s Cannabis Act. Situated in Ontario’s garden, Norfolk County, the company’s 44,000 sq ft production facility is engineered to meet strict quality standards. Once complete, it’s expected to produce 3,600kg of premium, organic cannabis per year. Canary intends to continue partnering with iconic cannabis brands like Serious Seeds, to bring the highest quality product to market. https://canaryrx.com/

CannaKorp, Inc. is a Massachusetts-based technology start-up that is simplifying and improving the experience for consumers interested in vaporizing natural herbs. CannaKorp has developed the world’s first single-use pod, herbal vaporizer system, delivering unprecedented quality, convenience and consistency. The complete system includes the ground breaking vaporizer device, WISP™, single-use, precisely measured pods containing pre-ground, lab-tested botanical herbs called WISP Pods™; and a proprietary pod-filling process. CannaKorp, Inc. was founded on care and commitment to patients and consumers, and is guided by a philosophy of social and environmental responsibility. https://wispvapor.com/


Serious Seeds is the home of classic, proprietary, award-winning cannabis strains such as AK-47, Bubble Gum, Chronic, Kali Mist, White Russian, and Serious Kush. Serious Seeds have been producing world renowned, premium cannabis strains since 1994. As of November 2018, Serious strains have received more than 101 cannabis industry awards globally. Their philosophy is to develop easy to grow, stable and homogenous genetics for medicinal and recreational cannabis consumers.http://seriouseeds.com/

Cannavolve assists cannabis brands to navigate government networks, build strong retail distribution and provide innovative marketing solutions. Founded on professional service standards and networks established in the Canadian beverage alcohol industry, by a team of executive level professionals with over 60 years of combined experience in alcohol, consumer packaged goods and medical business sectors in Canada. Cannavolve is Canada’s premier non-medical cannabis sales agency.https://cannavolve.ca/

LICENSED PRODUCER
Our subsidiary, Canary Rx Inc (“Canary”), is a Licensed Producer under the Cannabis Act.

THE FACILITY
Canary’s 44,000 sq. ft. custom-engineered facility is situated in Norfolk County, ON, with room to grow.

QUALITY
Canary will produce premium, small-batch cannabis, grown organically in soil, just as nature intended.

GLOBAL
Target Group is developing an international network of manufacturing, distribution, production and sales operations.

VERTICALLY INTEGRATED
Target has developed an exclusive portfolio of cannabis companies, across the entire seed-sale value-chain.

TARGETING SUCCESS
We’re targeting innovative and disruptive brands through strategic investment and partnerships.

FOCUSED ON CPGS
Target Group is developing data driven, premium, consumer packaged goods for the global market

RECENT NEWS